Trial Profile
Phase II trial of RDC 5 in patients with amytrophic lateral sclerosis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2014
Price :
$35
*
At a glance
- Drugs RDC 5 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- Sponsors Chronos Therapeutics
- 05 Feb 2014 New trial record